BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30892048)

  • 1. Serum Metabolomics Study of Nonsmoking Female Patients with Non-Small Cell Lung Cancer Using Gas Chromatography-Mass Spectrometry.
    Mu Y; Zhou Y; Wang Y; Li W; Zhou L; Lu X; Gao P; Gao M; Zhao Y; Wang Q; Wang Y; Xu G
    J Proteome Res; 2019 May; 18(5):2175-2184. PubMed ID: 30892048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
    Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
    J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum amino acid profiles' utility in non-small cell lung cancer detection in Polish population.
    Klupczynska A; Dereziński P; Dyszkiewicz W; Pawlak K; Kasprzyk M; Kokot ZJ
    Lung Cancer; 2016 Oct; 100():71-76. PubMed ID: 27597283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.
    Wikoff WR; Hanash S; DeFelice B; Miyamoto S; Barnett M; Zhao Y; Goodman G; Feng Z; Gandara D; Fiehn O; Taguchi A
    J Clin Oncol; 2015 Nov; 33(33):3880-6. PubMed ID: 26282655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
    PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and verification of coexisting diagnostic markers in plasma and serum of patients with non-small-cell lung cancer.
    Yu M; Sun R; Zhao Y; Shao F; Zhu W; Aa J
    Future Oncol; 2021 Nov; 17(32):4355-4369. PubMed ID: 34674559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary Study on the Biological Markers for I-IIb Stage Non-small Cell Lung Cancer Based on a Serum-peptidomics].
    Hou Y; Guo H; Guo Y; Zhang Y; Han H
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):20-25. PubMed ID: 30674389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study.
    Maeda J; Higashiyama M; Imaizumi A; Nakayama T; Yamamoto H; Daimon T; Yamakado M; Imamura F; Kodama K
    BMC Cancer; 2010 Dec; 10():690. PubMed ID: 21176209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
    Zhou Y; Song R; Ma C; Zhou L; Liu X; Yin P; Zhang Z; Sun Y; Xu C; Lu X; Xu G
    Oncotarget; 2017 Mar; 8(13):20719-20728. PubMed ID: 28157703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study.
    Ye S; Chen X; Yao Y; Li Y; Sun R; Zeng H; Shu Y; Yin H
    Sci Rep; 2019 Feb; 9(1):2652. PubMed ID: 30804354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
    Mazzone PJ; Wang XF; Beukemann M; Zhang Q; Seeley M; Mohney R; Holt T; Pappan KL
    J Thorac Oncol; 2016 Jan; 11(1):72-8. PubMed ID: 26762741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.
    Guergova-Kuras M; Kurucz I; Hempel W; Tardieu N; Kádas J; Malderez-Bloes C; Jullien A; Kieffer Y; Hincapie M; Guttman A; Csánky E; Dezso B; Karger BL; Takács L
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.010298. PubMed ID: 21947365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer.
    Xiang C; Jin S; Zhang J; Chen M; Xia Y; Shu Y; Guo R
    Int J Biol Markers; 2018 Aug; 33(3):314-320. PubMed ID: 29896992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
    O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
    Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
    J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non-small-cell lung cancer: A multicenter in vitro diagnostic clinical trial.
    Sun N; Sun S; Gao Y; Li Y; Lu Z; Yuan Z; Che Y; Huang J; Mao S; Lei Y; Zang R; Li N; Cui W; Qi J; Chen F; Gao J; Wang J; Min R; Chen Y; Shi G; Tan F; He J
    Cancer Sci; 2020 May; 111(5):1739-1749. PubMed ID: 32167618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.